norethindrone acetate has been researched along with Venous Thrombosis in 6 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hazard ratio for deep vein thrombosis (2 in treated group v 1 in control group) was 2." | 2.77 | Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. ( Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL, 2012) |
| " The aims of the present study were to evaluate a possible dose-response relationship and differential effects of different HT regimens on functionality of the APC system." | 2.73 | Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. ( Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM, 2007) |
| "However, the risk of venous thrombosis (VT) associated with OC use in women over 50 years old has never been assessed and the two preparations have not been directly compared." | 1.39 | The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. ( Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schierbeck, LL | 1 |
| Rejnmark, L | 1 |
| Tofteng, CL | 1 |
| Stilgren, L | 1 |
| Eiken, P | 1 |
| Mosekilde, L | 1 |
| Køber, L | 1 |
| Jensen, JE | 1 |
| Roach, RE | 1 |
| Lijfering, WM | 1 |
| Helmerhorst, FM | 1 |
| Cannegieter, SC | 1 |
| Rosendaal, FR | 1 |
| van Hylckama Vlieg, A | 1 |
| Schaudig, K | 1 |
| Thomssen, C | 1 |
| Eilertsen, AL | 1 |
| Liestøl, S | 1 |
| Mowinckel, MC | 2 |
| Hemker, HC | 1 |
| Sandset, PM | 2 |
| Keramaris, NC | 1 |
| Christodoulakos, GE | 1 |
| Lambrinoudaki, IV | 1 |
| Dalamanga, A | 1 |
| Alexandrou, AP | 1 |
| Bramis, J | 1 |
| Bastounis, E | 1 |
| Creatsas, GC | 1 |
| Høibraaten, E | 1 |
| Qvigstad, E | 1 |
| Andersen, TO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Danish Osteoporosis Prevention Study[NCT00252408] | Phase 4 | 2,000 participants | Interventional | 1990-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for norethindrone acetate and Venous Thrombosis
| Article | Year |
|---|---|
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle S | 2012 |
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, | 2007 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Dr | 2007 |
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Topics: Biomarkers; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Hemostasis; Hormone R | 2001 |
2 other studies available for norethindrone acetate and Venous Thrombosis
| Article | Year |
|---|---|
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; | 2013 |
Hormonal therapy with patch or pill: how much does it matter?
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; Drug Combinations; Estradiol; Es | 2007 |